Search All UT System Experts

Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial

Anthony Traboulsee, Benjamin M. Greenberg, Jeffrey L. Bennett, Lech Szczechowski, Edward Fox, Svitlana Shkrobot, Takashi Yamamura, Yusuke Terada, Yuichi Kawata, Padraig Wright, Athos Gianella-Borradori, Hideki Garren, Brian G. Weinshenker

Research output: Contribution to journal › Article › peer-review

269 Scopus citations

Fingerprint

Dive into the research topics of 'Safety and efficacy of satralizumab monotherapy in neuromyelitis optica spectrum disorder: a randomised, double-blind, multicentre, placebo-controlled phase 3 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences